DelSiTech provides drug delivery services within the pharmaceutical and biotech industries, specialising in the biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals, and viral vectors. The company focuses on parenteral and local administration of drug products.

Services include:
- Biodegradable silica-based controlled release formulations
- Drug delivery services for small molecule drugs
- Delivery of biopharmaceuticals
- Viral vector development and supply
- Contract manufacturing for drug products
- Customised formulation development

DelSiTech is committed to advancing drug delivery technologies and improving therapeutic outcomes for patients. For more information, please visit delsitech.com.